MARKSANS PHARMA U.K. LIMITED

05467597
Active Widnes

Activities of head offices

207 employees website.com
Life sciences and medical technology Activities of head offices
M

MARKSANS PHARMA U.K. LIMITED

05467597

Activities of head offices

Founded 31 May 2005 Active Widnes, United Kingdom 207 employees website.com
Life sciences and medical technology Activities of head offices
Accounts Submitted 4 Jun 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 2 Jun 2025 Next due 14 Jun 2026 3 days overdue
Net assets £87M £16M 2024 year on year
Total assets £96M £13M 2024 year on year
Total Liabilities £9M £3M 2024 year on year
Charges 3
3 outstanding

Contact & Details

Contact

Registered Address

Cheshire House Gorsey Lane Widnes Cheshire WA8 0RP

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MARKSANS PHARMA U.K. LIMITED (05467597), an active life sciences and medical technology company based in Widnes, United Kingdom. Incorporated 31 May 2005. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£30.69M

Increased by £73.65k (+0%)

Net Assets

£86.56M

Increased by £15.68M (+22%)

Total Liabilities

£9.24M

Decreased by £2.71M (-23%)

Turnover

£94.51M

Increased by £5.46M (+6%)

Employees

207

Decreased by 11 (-5%)

Debt Ratio

10%

Decreased by 4 (-29%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 104,376 Shares £104k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Mar 2017104,376£104k£1

Officers

Officers

2 active 1 resigned
Status
Chisnall, DanielDirectorBritishEngland301 Apr 2026Active
Sandra SaldanhaDirectorIndianIndia5431 May 2005Active

Shareholders

Shareholders (1)

Marksans Pharma Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Marksans Pharma Limited

India

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MARKSANS PHARMA U.K. LIMITED Current Company
RELONCHEM LIMITED united kingdom

Charges

Charges

3 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026AccountsAnnual accounts made up to 31 Mar 2026
15 Apr 2026OfficersAppointment of Mr Daniel Chisnall as director on 1 Apr 2026
1 Apr 2026OfficersTermination of John Stephen Molyneux as director on 31 Mar 2026
3 Jul 2025OfficersAppointment of Mr Daniel Chisnall as director on 25 Jun 2025
3 Jul 2025OfficersTermination of Seetharama Raju Buddharaju as director on 25 Jun 2025
4 Jun 2026 Accounts

Annual accounts made up to 31 Mar 2026

15 Apr 2026 Officers

Appointment of Mr Daniel Chisnall as director on 1 Apr 2026

1 Apr 2026 Officers

Termination of John Stephen Molyneux as director on 31 Mar 2026

3 Jul 2025 Officers

Appointment of Mr Daniel Chisnall as director on 25 Jun 2025

3 Jul 2025 Officers

Termination of Seetharama Raju Buddharaju as director on 25 Jun 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2026

1 weeks ago on 4 Jun 2026

Appointment of Mr Daniel Chisnall as director on 1 Apr 2026

2 months ago on 15 Apr 2026

Termination of John Stephen Molyneux as director on 31 Mar 2026

2 months ago on 1 Apr 2026

Appointment of Mr Daniel Chisnall as director on 25 Jun 2025

11 months ago on 3 Jul 2025

Termination of Seetharama Raju Buddharaju as director on 25 Jun 2025

11 months ago on 3 Jul 2025